Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 128

1.

Antibody-based profiling of cerebrospinal fluid within multiple sclerosis.

Häggmark A, Byström S, Ayoglu B, Qundos U, Uhlén M, Khademi M, Olsson T, Schwenk JM, Nilsson P.

Proteomics. 2013 Aug;13(15):2256-67. doi: 10.1002/pmic.201200580. Epub 2013 Jun 25.

PMID:
23696371
[PubMed - indexed for MEDLINE]
2.

CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.

Tumani H, Lehmensiek V, Rau D, Guttmann I, Tauscher G, Mogel H, Palm C, Hirt V, Suessmuth SD, Sapunova-Meier I, Ludolph AC, Brettschneider J.

Neurosci Lett. 2009 Mar 13;452(2):214-7. doi: 10.1016/j.neulet.2009.01.057. Epub 2009 Jan 29.

PMID:
19383442
[PubMed - indexed for MEDLINE]
3.

Effects of natalizumab treatment on the cerebrospinal fluid proteome of multiple sclerosis patients.

Stoop MP, Singh V, Stingl C, Martin R, Khademi M, Olsson T, Hintzen RQ, Luider TM.

J Proteome Res. 2013 Mar 1;12(3):1101-7. doi: 10.1021/pr3012107. Epub 2013 Feb 4.

PMID:
23339689
[PubMed - indexed for MEDLINE]
4.

A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases.

Menon KN, Steer DL, Short M, Petratos S, Smith I, Bernard CC.

Mol Cell Proteomics. 2011 Jun;10(6):M110.000042. doi: 10.1074/mcp.M110.000042. Epub 2011 Mar 18.

PMID:
21421798
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.

Teunissen CE, Koel-Simmelink MJ, Pham TV, Knol JC, Khalil M, Trentini A, Killestein J, Nielsen J, Vrenken H, Popescu V, Dijkstra CD, Jimenez CR.

Mult Scler. 2011 Jul;17(7):838-50. doi: 10.1177/1352458511399614. Epub 2011 Apr 19.

PMID:
21505015
[PubMed - indexed for MEDLINE]
6.

Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis.

Stoop MP, Singh V, Dekker LJ, Titulaer MK, Stingl C, Burgers PC, Sillevis Smitt PA, Hintzen RQ, Luider TM.

PLoS One. 2010 Aug 27;5(8):e12442. doi: 10.1371/journal.pone.0012442.

PMID:
20805994
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis.

Liu S, Bai S, Qin Z, Yang Y, Cui Y, Qin Y.

J Cell Mol Med. 2009 Aug;13(8A):1586-603. doi: 10.1111/j.1582-4934.2009.00850.x. Epub 2009 Jul 7.

PMID:
19602050
[PubMed - indexed for MEDLINE]
8.

Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.

Komori M, Matsuyama Y, Nirasawa T, Thiele H, Becker M, Alexandrov T, Saida T, Tanaka M, Matsuo H, Tomimoto H, Takahashi R, Tashiro K, Ikegawa M, Kondo T.

Ann Neurol. 2012 May;71(5):614-23. doi: 10.1002/ana.22633.

PMID:
22522477
[PubMed - indexed for MEDLINE]
9.

Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers.

Ottervald J, Franzén B, Nilsson K, Andersson LI, Khademi M, Eriksson B, Kjellström S, Marko-Varga G, Végvári A, Harris RA, Laurell T, Miliotis T, Matusevicius D, Salter H, Ferm M, Olsson T.

J Proteomics. 2010 Apr 18;73(6):1117-32. doi: 10.1016/j.jprot.2010.01.004. Epub 2010 Jan 20.

PMID:
20093204
[PubMed - indexed for MEDLINE]
10.

Miniaturized parallelized sandwich immunoassays.

Hsu HY, Wittemann S, Joos TO.

Methods Mol Biol. 2008;428:247-61.

PMID:
18287778
[PubMed - indexed for MEDLINE]
11.

Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.

Comabella M, Fernández M, Martin R, Rivera-Vallvé S, Borrás E, Chiva C, Julià E, Rovira A, Cantó E, Alvarez-Cermeño JC, Villar LM, Tintoré M, Montalban X.

Brain. 2010 Apr;133(Pt 4):1082-93. doi: 10.1093/brain/awq035. Epub 2010 Mar 17.

PMID:
20237129
[PubMed - indexed for MEDLINE]
Free Article
12.

Profiling and identification of cerebrospinal fluid proteins in a rat EAE model of multiple sclerosis.

Rosenling T, Stoop MP, Attali A, van Aken H, Suidgeest E, Christin C, Stingl C, Suits F, Horvatovich P, Hintzen RQ, Tuinstra T, Bischoff R, Luider TM.

J Proteome Res. 2012 Apr 6;11(4):2048-60. doi: 10.1021/pr201244t. Epub 2012 Feb 23.

PMID:
22320401
[PubMed - indexed for MEDLINE]
13.

Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels.

Calabrese V, Scapagnini G, Ravagna A, Bella R, Foresti R, Bates TE, Giuffrida Stella AM, Pennisi G.

J Neurosci Res. 2002 Nov 15;70(4):580-7.

PMID:
12404512
[PubMed - indexed for MEDLINE]
14.

Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.

Vogt MH, Teunissen CE, Iacobaeus E, Heijnen DA, Breij EC, Olsson T, Brundin L, Killestein J, Dijkstra CD.

J Neurol Neurosurg Psychiatry. 2009 Oct;80(10):1110-5. doi: 10.1136/jnnp.2008.146357. Epub 2008 Oct 17.

PMID:
18931010
[PubMed - indexed for MEDLINE]
15.

Highly multiplexed antibody suspension bead arrays for plasma protein profiling.

Drobin K, Nilsson P, Schwenk JM.

Methods Mol Biol. 2013;1023:137-45. doi: 10.1007/978-1-4614-7209-4_8.

PMID:
23765623
[PubMed - indexed for MEDLINE]
16.

[Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].

Drulović J, Stojsavljević N, Dujmović I, Sokić D, Mavra M, Lević Z.

Srp Arh Celok Lek. 1995 Jul-Aug;123(7-8):191-3. Serbian.

PMID:
17974427
[PubMed - indexed for MEDLINE]
17.

Comparative protein profiling of serum and plasma using an antibody suspension bead array approach.

Schwenk JM, Igel U, Kato BS, Nicholson G, Karpe F, Uhlén M, Nilsson P.

Proteomics. 2010 Feb;10(3):532-40. doi: 10.1002/pmic.200900657.

PMID:
19953555
[PubMed - indexed for MEDLINE]
18.

Proteome profiling of human cerebrospinal fluid: exploring the potential of capillary electrophoresis with surface modified capillaries for analysis of complex biological samples.

Zuberovic A, Hanrieder J, Hellman U, Bergquist J, Wetterhall M.

Eur J Mass Spectrom (Chichester, Eng). 2008;14(4):249-60. doi: 10.1255/ejms.929.

PMID:
18756023
[PubMed - indexed for MEDLINE]
19.

Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.

Augutis K, Axelsson M, Portelius E, Brinkmalm G, Andreasson U, Gustavsson MK, Malmeström C, Lycke J, Blennow K, Zetterberg H, Mattsson N.

Mult Scler. 2013 Apr;19(5):543-52. doi: 10.1177/1352458512460603. Epub 2012 Oct 15.

PMID:
23069872
[PubMed - indexed for MEDLINE]
20.

Discovery and initial verification of differentially abundant proteins between multiple sclerosis patients and controls using iTRAQ and SID-SRM.

Kroksveen AC, Aasebø E, Vethe H, Van Pesch V, Franciotta D, Teunissen CE, Ulvik RJ, Vedeler C, Myhr KM, Barsnes H, Berven FS.

J Proteomics. 2013 Jan 14;78:312-25. doi: 10.1016/j.jprot.2012.09.037. Epub 2012 Oct 8.

PMID:
23059536
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk